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African Swine Fever (ASF) is a highly contagious, viral disease of pigs caused by an Asfivirus (Fig.1). It can cause up to 100% of mortality in domestic pigs and European wild 
boars, although varying degrees of virulence have been shown. In contrast, the infection is unapparent in African wild suids (warthogs, bush pigs, giant forest hogs). There is no 
treatment or vaccine to control this severe disease. To address this issue, we are currently working on the development of an attenuated vaccine and new generation of biological 
antivirals. For the generation of attenuated ASFV vaccine strains, we envisage to delete the 10 Kb region located 23638-33336 in the genome (Fig. 2), which includes nine genes 
that are thought to determine the virulence of ASFV. Of these 9 genes, 4 (A104R, A118R, A151R and A240L) have unknown function in the virus replication cycle. To establish the 
importance of these genes, we have used the RNA interference approach. RNA interference is a natural biological process initially described in plants [1]. It is a natural cell 
mechanism by which small interfering RNAs (siRNAs) of about 20 nucleotides operate to down regulate the expression of a gene by targeting and cleaving its mRNA (post-
transcriptional gene silencing).
MATERIAL AND METHODS
 siRNA design
The four genes of interest (A104R, A118R, A151R and A240L), position 30166-
31949 (Fig. 2) and also B646L (VP72)  gene (as a control for essential gene), from 
a Spanish strain isolated in 1971 were cloned, sequenced and the sequence results 
were compared with the reference sequence available in GenBank (accession 
number ASU18466). The sequences were sent to Ambion-Applied Biosystems for 
siRNA design. Seventeen siRNAs were received, 3 were direct against each of the 
4 genes of interest and 5 were direct against B646L mRNA. 
 siRNA-transfection
Vero cells were transfected with different doses of each of these siRNA using 
Qiagen HiPerfect reagent and 24 hours after, cells were infected with Ba71v virus. 
Three days later, siRNAs silencing effect were evaluated by measuring Ba71v 
Cytopathic Effect (CPE) and by virus titration.
 CPE quantification
The siRNA effects were evaluated by direct microscopic observation of the cells 
and then after blue trypan staining. A score of CPE severity was attributed and 
being – for no CPE to +++ (> 70% of CPE). 
 Virus titration
To evaluate the virus progeny replication, ten-fold 
serial dilutions of the cell supernatant were 
inoculated onto Vero cells. The titre in TCID50/ml 
was established according to Reed and Muench
(1938).
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Fig. 3: siRNA functionality measured by microscopic observation of CPE (A) and virus titration (A, B).
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Fig. 1: African Swine Fever Virus (ASFV): Asfivirus Fig. 2: Position of the 5 interesting genes in the ASFV 
genome
siRNA functionality
Cytopathic effect was decreased by the three siRNA targeting the 
gene A151R, the siRNA A104R-3 and A240L-3 (Fig. 3.A). 
Accordingly, the virus titres were reduced by 1 to 3 log10
depending on the type and concentration of siRNA (Fig. 3.B). 
However, the effect of siRNA targeting the essential gene VP72 
was surprisingly low. siRNA directed against A118R gene showed 
no or a very weak effect on the CPE and Virus Titres (Fig. 3).
The most efficient sequences were siRNA-A151R-2 and A151-3 
with a clear CPE reduction (Fig. 4.A) )and up to 2.4-3 log 
reduction of the virus titre (Fig. 4.B).
 In this study, we have evidenced the essential role of the A151R gene in Ba71v  
replication. Three siRNA were active against this gene with clear effect on virus 
replication. Therefore, an extra-copy of this gene will have to be inserted in the 
ASFv genome before attenuation by deleting the 10 kb which contain the original 
gene.
 The possibility to use these active sequences as potential antivirals in vivo will 
be also explored since in the absence of a vaccine, such strategy could become a 
useful alternative control strategy. 
 The essential role of the three other genes of interest is not clearly established: 
some siRNA may have slight effect on CPE and virus titres, but further 
confirmation is needed. Thus, the effect of these siRNAs on the different  gene 
transcripts will be soon assessed by real-time PCR.
 Finally, the lack of siRNA effect, in particular against the essential B646L (VP72) 
gene, may probably result from the incorrect design of the sequences. Further 
siRNA design is ongoing.
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Fig. 4: siRNAs A151R silencing effect measured by microscopic 
observation (A) and virus titration (B).
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